Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas.

Fortin Ensign S, Bollin K, Millis SZ, Hinds BR, Kosty M, Uchiyama C.

Pigment Cell Melanoma Res. 2019 Oct 30. doi: 10.1111/pcmr.12839. [Epub ahead of print]

PMID:
31663661
2.

The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.

Disel U, Madison R, Abhishek K, Chung JH, Trabucco SE, Matos AO, Frampton GM, Albacker LA, Reddy V, Karadurmus N, Benson A, Webster J, Paydas S, Cabanillas R, Nangia C, Ozturk MA, Millis SZ, Pal SK, Wilky B, Sokol ES, Gay LM, Soman S, Ganesan S, Janeway K, Stephens PJ, Zhu VW, Ou SI, Lovly CM, Gounder M, Schrock AB, Ross JS, Miller VA, Klempner SJ, Ali SM.

Oncologist. 2020 Jan;25(1):e39-e47. doi: 10.1634/theoncologist.2018-0528. Epub 2019 Oct 11.

3.

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.

Seligson ND, Awasthi A, Millis SZ, Turpin BK, Meyer CF, Grand'Maison A, Liebner DA, Hays JL, Chen JL.

JAMA Netw Open. 2019 Oct 2;2(10):e1912416. doi: 10.1001/jamanetworkopen.2019.12416.

4.

Frequency of Electrodiagnostically Measurable Berrettini Anastomosis.

Seidel GK, Seidel ME, Hakopian D, Alabdulkarim M, Rahman A, Andary MT, Millis SR.

J Clin Neurophysiol. 2019 Jul 23. doi: 10.1097/WNP.0000000000000622. [Epub ahead of print]

PMID:
31348110
5.

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma.

Ang C, Klempner SJ, Ali SM, Madison R, Ross JS, Severson EA, Fabrizio D, Goodman A, Kurzrock R, Suh J, Millis SZ.

Oncotarget. 2019 Jun 18;10(40):4018-4025. doi: 10.18632/oncotarget.26998. eCollection 2019 Jun 18.

6.

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.

Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, Frampton GM, Bratslavsky G, Pal SK, Lee RJ, Necchi A, Gregg JP, Lara P Jr, Antonarakis ES, Miller VA, Ross JS, Ali SM, Agarwal N.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00283. Epub 2019 May 10.

7.

Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.

Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS.

Mod Pathol. 2019 Nov;32(11):1593-1604. doi: 10.1038/s41379-019-0301-1. Epub 2019 Jun 12.

PMID:
31189996
8.

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL.

Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24.

9.

End tidal CO2 and cerebral oximetry for the prediction of return of spontaneous circulation during cardiopulmonary resuscitation.

Engel TW 2nd, Thomas C, Medado P, Bastani A, Reed B, Millis S, O'Neil BJ.

Resuscitation. 2019 Jun;139:174-181. doi: 10.1016/j.resuscitation.2019.04.006. Epub 2019 Apr 9.

PMID:
30978377
10.

Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.

Necchi A, Bratslavsky G, Chung J, Millis S, Gay LM, Ali SM, Ross JS.

Oncologist. 2019 Apr;24(4):e142-e145. doi: 10.1634/theoncologist.2018-0430. Epub 2019 Jan 18.

11.

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.

Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, Kurzrock R.

Cancer. 2019 Apr 1;125(7):1185-1199. doi: 10.1002/cncr.31921. Epub 2018 Dec 24.

12.

The relation between cognitive dysfunction and diffusion tensor imaging parameters in traumatic brain injury.

Hanks R, Millis S, Scott S, Gattu R, O'Hara NB, Haacke M, Kou Z.

Brain Inj. 2019;33(3):355-363. doi: 10.1080/02699052.2018.1553073. Epub 2018 Dec 19.

PMID:
30563361
13.

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.

Seligson ND, Kautto EA, Passen EN, Stets C, Toland AE, Millis SZ, Meyer CF, Hays JL, Chen JL.

Oncologist. 2019 Jul;24(7):973-979. doi: 10.1634/theoncologist.2018-0448. Epub 2018 Dec 12.

14.

Outcomes after Concussion Recovery Education: Effects of Litigation and Disability Status on Maintenance of Symptoms.

Hanks RA, Rapport LJ, Seagly K, Millis SR, Scott C, Pearson C.

J Neurotrauma. 2019 Feb 15;36(4):554-558. doi: 10.1089/neu.2018.5873. Epub 2018 Sep 6.

PMID:
30117361
15.

Cognitive Log performance among individuals without brain injury in an inpatient rehabilitation setting.

McLaughlan JK, Vos L, Waldron-Perrine B, Sherman T, Millis SR.

Rehabil Psychol. 2018 Aug;63(3):479-485. doi: 10.1037/rep0000236.

PMID:
30113203
16.

Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.

Kaplan HG, Rostad S, Ross JS, Ali SM, Millis SZ.

J Natl Compr Canc Netw. 2018 Aug;16(8):967-974. doi: 10.6004/jnccn.2018.7033.

PMID:
30099373
17.

Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.

Necchi A, Bratslavsky G, Corona RJ, Chung JH, Millis SZ, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Severson E, Daniel S, Killian JK, Ali SM, Schrock AB, Reddy P, Miller VA, Welsh A, Gay LM, Ross JS.

Eur Urol Focus. 2020 Jan 15;6(1):122-130. doi: 10.1016/j.euf.2018.07.013. Epub 2018 Jul 17.

PMID:
30025711
18.

Response to Checkpoint Inhibitor Therapy in Advanced Classic Kaposi Sarcoma: A Case Report and Immunogenomic Study.

Saller J, Walko CM, Millis SZ, Henderson-Jackson E, Makanji R, Brohl AS.

J Natl Compr Canc Netw. 2018 Jul;16(7):797-800. doi: 10.6004/jnccn.2018.7018.

PMID:
30006421
19.

Social Competence Treatment After Traumatic Brain Injury: A Multicenter, Randomized Controlled Trial of Interactive Group Treatment Versus Noninteractive Treatment.

Harrison-Felix C, Newman JK, Hawley L, Morey C, Ketchum JM, Walker WC, Bell KR, Millis SR, Braden C, Malec J, Hammond FM, Eagye CB, Howe L.

Arch Phys Med Rehabil. 2018 Nov;99(11):2131-2142. doi: 10.1016/j.apmr.2018.05.030. Epub 2018 Jun 30.

PMID:
29966645
20.

MRI and Neuropsychological Correlates in African Americans With Hypertension and Left Ventricular Hypertrophy.

Waldron-Perrine B, Kisser JE, Brody A, Haacke EM, Dawood R, Millis S, Levy P.

Am J Hypertens. 2018 Jul 16;31(8):865-868. doi: 10.1093/ajh/hpy060.

21.

A Chemical-Biological-Radio-Nuclear (CBRN) Filter can be Added to the Air-Outflow Port of a Ventilator to Protect a Home Ventilated Patient From Inhalation of Toxic Industrial Compounds.

Be'eri E, Owen S, Beeri M, Millis SR, Eisenkraft A.

Disaster Med Public Health Prep. 2018 Dec;12(6):739-743. doi: 10.1017/dmp.2018.3. Epub 2018 Feb 21.

22.

Safety and effectiveness of high-dose, weight-based factor VIII inhibitor bypassing activity for warfarin-induced life-threatening bleeding.

Messana EA, Saely S, Millis SR, Levy PD.

Blood Coagul Fibrinolysis. 2018 Mar;29(2):205-210. doi: 10.1097/MBC.0000000000000705.

PMID:
29369079
23.

Predictors of readmission to acute care during inpatient rehabilitation for non-traumatic spinal cord injury.

Robinson DM, Bazzi MS, Millis SR, Bitar AA.

J Spinal Cord Med. 2018 Jul;41(4):444-449. doi: 10.1080/10790268.2018.1426235. Epub 2018 Jan 22.

24.

Emergency department visits in patients with low acuity conditions: Factors associated with resource utilization.

Pearson C, Kim DS, Mika VH, Imran Ayaz S, Millis SR, Dunne R, Levy PD.

Am J Emerg Med. 2018 Aug;36(8):1327-1331. doi: 10.1016/j.ajem.2017.12.033. Epub 2017 Dec 13.

PMID:
29277493
25.

Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.

Gupta S, Albertson D, Gaston D, Heilbrun ME, Agarwal N, Boucher K, Parnell TJ, Liu T, Morgans A, Madison R, Gowen K, Miller VA, Ross JS, Ali SM, Millis SZ.

Clin Genitourin Cancer. 2018 Apr;16(2):e373-e382. doi: 10.1016/j.clgc.2017.09.001. Epub 2017 Sep 7.

PMID:
28974397
26.

Blood pressure variability as an indicator of sepsis severity in adult emergency department patients.

Nouriel JE, Millis SR, Ottolini J, Wilburn JM, Sherwin RL, Paxton JH.

Am J Emerg Med. 2018 Apr;36(4):560-566. doi: 10.1016/j.ajem.2017.09.017. Epub 2017 Sep 14.

PMID:
28967450
27.

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.

Bieg-Bourne CC, Millis SZ, Piccioni DE, Fanta PT, Goldberg ME, Chmielecki J, Parker BA, Kurzrock R.

Cancer Res. 2017 Nov 15;77(22):6313-6320. doi: 10.1158/0008-5472.CAN-17-1569. Epub 2017 Sep 22.

28.

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation.

Ang C, Stollman A, Zhu H, Sarpel U, Scarborough B, Sahni G, Millis SZ.

Case Rep Oncol. 2017 Jun 22;10(2):548-552. doi: 10.1159/000477562. eCollection 2017 May-Aug.

29.

Hemodynamic characteristics of suspected stroke in the emergency department.

Miller JB, Nowak RM, Reed BP, DiSomma S, Nanayakkara P, Moyer M, Millis S, Kinni H, Levy P.

Am J Emerg Med. 2017 Dec;35(12):1915-1918. doi: 10.1016/j.ajem.2017.08.017. Epub 2017 Aug 8.

PMID:
28811213
30.

Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.

Abbosh P, Sundararajan S, Millis SZ, Hauben A, Reddy S, Geynisman DM, Uzzo R.

Eur Urol Focus. 2018 Dec;4(6):969-971. doi: 10.1016/j.euf.2017.01.003. Epub 2017 Jan 23.

PMID:
28753842
31.

Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.

Joshi M, Millis SZ, Arguello D, Holder SL, Lamm D, Reddy S, Belani C, Drabick JJ, Vogelzang NJ.

Eur Urol Focus. 2018 Jan;4(1):94-97. doi: 10.1016/j.euf.2016.06.011. Epub 2016 Jun 24.

32.

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.

Bernitsas E, Khan O, Razmjou S, Tselis A, Bao F, Caon C, Millis S, Seraji-Bozorgzad N.

PLoS One. 2017 Jul 20;12(7):e0181431. doi: 10.1371/journal.pone.0181431. eCollection 2017.

33.

Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.

Seraji-Bozorgzad N, Khan O, Cree BAC, Bao F, Caon C, Zak I, Razmjou S, Tselis A, Millis S, Bernitsas E.

J Neuroimaging. 2017 Sep;27(5):476-480. doi: 10.1111/jon.12435. Epub 2017 Mar 29.

PMID:
28371088
34.

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.

Borazanci E, Millis SZ, Kimbrough J, Doll N, Von Hoff D, Ramanathan RK.

J Gastrointest Oncol. 2017 Feb;8(1):164-172. doi: 10.21037/jgo.2017.01.14.

35.

Rasch analysis of alcohol abuse and dependence diagnostic criteria in persons with spinal cord injury.

Reslan S, Kalpakjian CZ, Hanks RA, Millis SR, Bombardier CH.

Spinal Cord. 2017 May;55(5):497-501. doi: 10.1038/sc.2016.146. Epub 2017 Feb 28.

PMID:
28244502
36.

Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department.

Ayaz SI, Sharkey CM, Kwiatkowski GM, Wilson SS, John RS, Tolomello R, Mahajan A, Millis S, Levy PD.

Int J Emerg Med. 2016 Dec;9(1):28. doi: 10.1186/s12245-016-0125-4. Epub 2016 Dec 28.

37.

Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, Papa L.

J Neurotrauma. 2017 Jun 1;34(11):1957-1971. doi: 10.1089/neu.2016.4772. Epub 2017 Feb 27.

38.

Presenting phenotypes of acute heart failure patients in the ED: Identification and implications.

Nowak RM, Reed BP, DiSomma S, Nanayakkara P, Moyer M, Millis S, Levy P.

Am J Emerg Med. 2017 Apr;35(4):536-542. doi: 10.1016/j.ajem.2016.12.003. Epub 2016 Dec 8.

PMID:
27986335
39.

Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure.

Wilson SS, Kwiatkowski GM, Millis SR, Purakal JD, Mahajan AP, Levy PD.

Am J Emerg Med. 2017 Jan;35(1):126-131. doi: 10.1016/j.ajem.2016.10.038. Epub 2016 Oct 18.

PMID:
27825693
40.

Survey of Emergency Physician Approaches to Management of Asymptomatic Hypertension.

Brody A, Twiner M, Kumar A, Goldberg E, McNaughton C, Souffront K, Millis S, Levy PD.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):265-269. doi: 10.1111/jch.12921. Epub 2016 Sep 28.

41.

Barriers to emergency physician diagnosis and treatment of uncontrolled chronic hypertension.

Brody AM, Sharma VK, Singh A, Kumar VA, Goldberg EM, Millis SR, Levy PD.

Am J Emerg Med. 2016 Nov;34(11):2241-2242. doi: 10.1016/j.ajem.2016.08.050. Epub 2016 Aug 27. No abstract available.

PMID:
27623082
42.

Presenting hemodynamic phenotypes in ED patients with confirmed sepsis.

Nowak RM, Reed BP, Nanayakkara P, DiSomma S, Moyer ML, Millis S, Levy P.

Am J Emerg Med. 2016 Dec;34(12):2291-2297. doi: 10.1016/j.ajem.2016.08.031. Epub 2016 Aug 16.

PMID:
27613360
43.

Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors.

Millis SZ, Ikeda S, Reddy S, Gatalica Z, Kurzrock R.

JAMA Oncol. 2016 Dec 1;2(12):1565-1573. doi: 10.1001/jamaoncol.2016.0891.

PMID:
27388585
44.

Prevalence of below-criterion Reliable Digit Span scores in a clinical sample of older adults.

Zenisek R, Millis SR, Banks SJ, Miller JB.

Arch Clin Neuropsychol. 2016 Aug;31(5):426-33. doi: 10.1093/arclin/acw025. Epub 2016 May 8.

45.

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.

Friedlander ML, Russell K, Millis S, Gatalica Z, Bender R, Voss A.

Int J Gynecol Cancer. 2016 May;26(4):648-54. doi: 10.1097/IGC.0000000000000677.

46.

Correlates of resilience in the first 5 years after traumatic brain injury.

Hanks RA, Rapport LJ, Waldron Perrine B, Millis SR.

Rehabil Psychol. 2016 Aug;61(3):269-276. doi: 10.1037/rep0000069. Epub 2016 Feb 8.

PMID:
26855130
47.

Delegates view deployable military hospital.

Millis S.

Nurs N Z. 2015 Nov;21(10):33. No abstract available.

PMID:
26717634
48.

Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.

Millis SZ, Ejadi S, Demeure MJ.

Biomark Cancer. 2015 Dec 17;7:69-76. doi: 10.4137/BIC.S34292. eCollection 2015.

49.

Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.

Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa GK.

J Surg Oncol. 2016 Jan;113(1):55-61. doi: 10.1002/jso.24086. Epub 2015 Dec 10.

PMID:
26661118
50.

Characterization of Human Rib Biomechanical Responses due to Three-Point Bending.

Kalra A, Saif T, Shen M, Jin X, Zhu F, Begeman P, Yang KH, Millis S.

Stapp Car Crash J. 2015 Nov;59:113-30.

PMID:
26660742

Supplemental Content

Loading ...
Support Center